Subscribe To
HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
BOSTON, May 12, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended March 31, 2023, highlighted recent progress and outlined key upcoming milestones for HIL-214, the company’s investigational virus-like particle (VLP) based vaccine for the prevention of […] The post HilleVax Reports First Quarter 2023 Financial Results and Highlights Recen...
Read More
Posted: May 12 2023, 20:05
Author Name: forextv
Views: 110683